Kepos Capital LP Biom X Inc. Transaction History

Kepos Capital LP

  • $228 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$6.4 - $20.2 $2.88 Million - $9.1 Million
-450,597 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$30.6 - $58.1 $13.8 Million - $26.2 Million
450,597 New
450,597 $1.38 Million

Others Institutions Holding PHGE

# of Institutions
2
Shares Held
301K
Call Options Held
0
Put Options Held
0
View Full List

About BiomX Inc.

PHGE Quotes by TradingView
  • Ticker PHGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,982,300
  • Market Cap $19.2M
  • Description
  • BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...
More about PHGE
Track This Portfolio

Track Kepos Capital LP Portfolio

Follow Kepos Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Kepos Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email